Our Commitment
Humanity faces great challenges. We believe that we can always do more - for ourselves and for future generations.
Search
Making sustainable medicines through eco-design
Our goal is to minimize the environmental footprint of our medicines through integration of eco-design and green chemistry across the entire lifecycle
Unleashing Innovation at Boehringer Ingelheim
Join us at our upcoming seminar and networking event where we'll share our unique approach to fostering innovation and supporting startups. We're excited to introduce you to Research Beyond Borders, our approach to open science: opnMe.com
Reimagining digital healthcare worldwide
How does our digital lab BI X innovate in Ingelheim and Shanghai? Read about success stories based on different ideation processes
Computational Biology & Digital Sciences
At Boehringer Ingelheim, we are investing into the power of computational biology and data sciences to accelerate the journey from scientific discoveries to breakthrough therapies.
Boehringer Ingelheim Office Hours 2024: Shaping the Future of Innovation in Europe
Boehringer Ingelheim is actively supporting the next generation of innovators.
The domino effect of cardiovascular, renal and metabolic conditions
The domino effect of cardiovascular, renal and metabolic conditions
Veterinarians go above and (far) beyond.
Veterinarians go above and (far) beyond.
Making a difference in clinical trials: The impact of engagement
We are partnering with patients, caregivers and trial site staff to design and conduct our clinical trials, to provide a better experience for all.
We are there for our patients – even in crisis regions.
We are there for our patients – even in crisis regions.
Boehringer Ingelheim Awards Innovation Prize to Ablevia
Innovative solution from Ablevia for rapid and selective elimination of harmful antibodies without impediment to the immune system
The global $1 trillion mental health problem needs more funding
Nearly one billion people around the world live with a mental health condition, yet an estimated 70% don’t have access to the help they need.
The Oscars of Science
Revolutionary advances in physics and chemistry used at Boehringer Ingelheim
Patients in Focus
Boehringer Ingelheim RCV provides over six million patients with innovative therapies. Ensuring that the patients’ needs at every stage are met precisely is of decisive importance.
Pioneering New Medicines Through External Innovation
On 22 November 2024 Boehringer Ingelheim hosted the event “Unleashing Innovation at Boehringer Ingelheim: Pioneering New Medicines Through External Innovation” at the Institute of Molecular Pathology (IMP)
Small Molecule Drug Discovery
Boehringer Ingelheim scientists continue to expand the horizons of what small molecule drugs can achieve.
Boehringer Ingelheim’s Postdoctoral Program
Boehringer Ingelheim’s postdoctoral program in Regional Center Vienna (RCV) provides scientists with the opportunity to pursue research.
Always Here – Our Commitment for Ukraine
Boehringer Ingelheim has actively supported Ukrainian civilians throughout the Russian invasion.